Glucagonoma

1 paper

Trial sponsors

National Cancer Institute
2 trialsPhase 2108 people
ECOG-ACRIN Cancer Research Group
1 trialPhase 22 people
Emory University
1 trialPhase 22 people
Mayo Clinic
1 trialPhase 196 people

Latest

ENDO 2025 Abstract23 Oct

MON-037 GLP-1 Receptor Agonists in MEN1-Associated Glucagonoma: Exploring Glycemic Control and Tumor Stability

Case reportGLP-1 receptor agonists